ENDOTHELIN RECEPTOR--PURIFICATION AND CHARACTERIZATION
ENDOTHELIN RECEPTOR--PURIFICATION AND CHARACTERIZATION
批准号:
3087705
负责人:
MICHAEL D GUNN
金额:
$8.65万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 1994-07-31
关键词:
Xenopus affinity chromatography biological signal transduction blood vessel disorder calcium flux chemical structure function cow endothelin gel electrophoresis heart cell high performance liquid chromatography hypertension ion exchange chromatography molecular cloning muscle tone nuclear magnetic resonance spectroscopy nucleic acid probes peptide chemical synthesis protein purification protein structure function pulmonary hypertension radionuclides receptor binding receptor expression site directed mutagenesis tissue /cell culture vascular resistance vascular smooth muscle vasoconstrictors vasospasm
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Numerous cardiovascular diseases involve alterations in vascular tone and
resistance to blood flow. These include systemic and pulmonary
hypertension and acute coronary and cerebral artery vasospasm. It is now
known that the vascular endothelium produces important vaso-regulatory
substances which mediate vascular smooth muscle tone. One such substance
is endothelin, the most potent vasoconstrictor polypeptide known to date.
The long term goal of this proposal is to understand the role of
endothelin in vascular disease and to develop methods of blocking its
pathological effects.
Endothelin acts by binding to high affinity receptors on the surface of
vascular smooth muscle cells. The aim of this project is to purify the
endothelin receptor and use it to study the mechanism of endothelin
action. In order to do this, our specific aims are to determine the
important structural features of the endothelin molecule, to determine
the endothelin binding characteristics of various tissues, to purify,
clone, and sequence the endothelin receptor, and to use mutated forms of
the receptor to study endothelin's signaling pathways. This work will
utilize newer biochemical techniques including the use of nuclear
magnetic resonance spectroscopy to determine the three dimensional
structure of endothelin and expression cloning as a means to isolate the
endothelin receptor. We have the ability to synthesize functional
endothelin derivatives, which may allow the production of specific
endothelin antagonists.
Preliminary studies have shown that endothelin receptor stimulation
causes a marked increase in intracellular calcium and may be coupled to
opening of the voltage activated calcium channel. Site directed
mutagenesis will allow us to study the mechanism of this and other
signaling pathways important to cell biology. The results of these
investigations should provide a better understanding of the basic aspects
of endothelin action and should aid in the development of new approaches
to the study and treatment of vascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of point-of-care testing for Lassa and other hemorrhagic fever arenaviruses
-
批准号:10656548
-
项目类别:
-
资助金额:$39.7万
-
财政年份:2022
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
-
批准号:10092930
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2020
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
-
批准号:9896170
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2020
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10246886
-
项目类别:
-
资助金额:$56.58万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10477339
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma
-
批准号:10006178
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2018
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of Zika virus-specific recombinant antibodies
-
批准号:9226804
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2016
-
负责人:MICHAEL D GUNN
-
依托单位:
Generation of Zika virus-specific recombinant antibodies
-
批准号:9331436
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2016
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10248330
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10248318
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
A novel cellular tumor vaccine strategy for mutant IDH1 glioma
-
批准号:10705246
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2014
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8468639
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8871680
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8839873
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Salmonella Single-chain Abs as serum diagnostics
-
批准号:8302016
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2012
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:7779310
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8607110
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8413658
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8434024
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
Development of anti-Aspergillus single chain Abs as serum and imaging diagnostics
-
批准号:8008766
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2010
-
负责人:MICHAEL D GUNN
-
依托单位:
海外基金